$50.15
0.54% yesterday
Nasdaq, Aug 11, 10:00 pm CET

Bio-Techne Corporation Stock price

$50.15
-3.99 7.37% 1M
-18.19 26.62% 6M
-21.88 30.38% YTD
-21.63 30.13% 1Y
-43.46 46.43% 3Y
-15.31 23.38% 5Y
+23.16 85.81% 10Y
+37.78 305.25% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.27 0.54%

Key metrics

Basic
Market capitalization
$7.9b
Enterprise Value
$8.1b
Net debt
$189.3m
Cash
$140.7m
Shares outstanding
156.8m
Valuation (TTM | estimate)
P/E
61.2 | 25.9
P/S
6.5 | 6.4
EV/Sales
6.7 | 6.5
EV/FCF
36.5
P/B
3.9
Dividends
DPS
$0.32
Yield 1Y | 5Y
0.6% | 0.4%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
30.5% | 21.5%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$1.2b | $1.2b
EBITDA
$329.1m | $431.5m
EBIT
$218.2m | $384.3m
Net Income
$131.7m | $305.7m
Free Cash Flow
$220.8m
Growth (TTM | estimate)
Revenue
-15.5% | 7.1%
EBITDA
-24.8% | 53.2%
EBIT
-33.3% | 54.7%
Net Income
-48.2% | 81.9%
Free Cash Flow
-12.1%
Margin (TTM | estimate)
Gross
66.4%
EBITDA
27.2% | 34.8%
EBIT
18.1%
Net
10.9% | 24.6%
Free Cash Flow
18.3%
Financial Health
Equity Ratio
76.5%
Return on Equity
8.1%
ROCE
8.8%
ROIC
7.2%
Debt/Equity
0.2
More
EPS
$0.8
FCF per Share
$1.4
Short interest
4.8%
Employees
3k
Rev per Employee
$370.0k
Show more

Is Bio-Techne Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Bio-Techne Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Bio-Techne Corporation forecast:

17x Buy
71%
7x Hold
29%

Analyst Opinions

24 Analysts have issued a Bio-Techne Corporation forecast:

Buy
71%
Hold
29%

Financial data from Bio-Techne Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,209 1,209
16% 16%
100%
- Direct Costs 406 406
14% 14%
34%
803 803
16% 16%
66%
- Selling and Administrative Expenses 487 487
4% 4%
40%
- Research and Development Expense 97 97
19% 19%
8%
329 329
25% 25%
27%
- Depreciation and Amortization 111 111
0% 0%
9%
EBIT (Operating Income) EBIT 218 218
33% 33%
18%
Net Profit 132 132
48% 48%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Bio-Techne Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bio-Techne Corporation Stock News

Neutral
The Motley Fool
5 days ago
Bio-Techne (TECH) Q4 EPS Rises 8.2%
Neutral
Seeking Alpha
6 days ago
Bio-Techne Corporation (NASDAQ:TECH ) Q4 2025 Earnings Conference Call August 6, 2025 9:00 AM ET Company Participants David Clair - VP of Investor Relations & Corporate Development James T. Hippel - Executive VP of Finance & CFO Kim Kelderman - CEO, President & Director Conference Call Participants Brandon Couillard - Wells Fargo Securities, LLC, Research Division Daniel Markowitz - Evercore IS...
Positive
Reuters
6 days ago
Bio-Techne reported better-than-expected fourth-quarter revenue and profit on Wednesday, helped by steady demand for its proteins, antibodies and other products for research.
More Bio-Techne Corporation News

Company Profile

Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community. The Protein Platforms segment develops, manufactures, and sells tools to simplify protein analysis. The Diagnostics segment includes blood chemistry and blood gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market worldwide. The company was founded on 1976 and is headquartered in Minneapolis, MN.

Head office United States
CEO Kim Kelderman
Employees 3,100
Founded 1976
Website www.bio-techne.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today